decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 5 (May)
Distal Embolic Protection Device Is Unbillable
Subscribe or sign in to view the full article.
Article Overview
This article discusses American College of Cardiology guidance on reporting distal embolic protection in connection with coronary stenting, PTCA, and related cardiology services. It is aimed at medical coders, cardiology practices, and billing staff who need to understand whether the service is separately reportable, how payers may view unlisted codes or modifiers, and how carrier policy can affect reimbursement. The article also touches on Medicare and private payer coverage considerations and references a clinical-trial-only context for carotid stenting.
Why This Topic Matters
Distal embolic protection became more common in interventional cardiology, creating uncertainty about whether it should be billed separately or treated as part of the primary procedure. Accurate understanding of the guidance helps practices avoid unbundling problems, overpayment risk, and claim denials.
What You Will Learn
- How the article frames distal embolic protection in coronary and carotid procedures
- What broad reimbursement and coverage issues are discussed
- How payer policy and carrier guidance can affect reporting decisions
- What types of coding options and modifier considerations are mentioned at a high level
Who Should Read This
- Cardiology coders
- Medical billing staff
- Interventional cardiology practices
- Compliance staff
- Revenue cycle professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com